Skip to main content

Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.

Calvano CD, Aresta A, Iacovone M, De Benedetto GE, Zambonin CG, Battaglia M, Ditonno P, Rutigliano M, Bettocchi C

Publication: J Pharm Biomed Anal (2010) • Vol 51 • Page 907-14PMID: 19939598View on PubMed

Purpose

This paper investigated the optimization of urine analysis by MALDI-TOF MS and examined the effects of storage of urine and diagnosis of prostate cancer on the protein profile.

Conclusion

The largest number of peaks and highest peak intensities were obtained when urine was prepared using homemade hydrophilic–lipophilic balance (HLB) cartridges and was deposited by spin coating at a 1:1 ratio with the CHCA matrix. The protein profile was less affected by storage at -20˚C than 4˚C. Although the profile was altered after only two days of storage at 4˚C, effects of storage at -20˚C were first observed after 35 days.

Studies (2)

Purpose

This study investigated the effect of sample preparation method as well as matrix type, matrix to analyte ratio, and sample deposition on the MALDI-TOF MS spectra of a single urine specimen. The effect of prostate cancer on the protein profile was also investigated. Mid-stream early morning urine from a healthy patient was acidified to pH 3.0 with 0.5M phosphoric acid and centrifuged at 5000 x g for 10 min. Proteins were prepared with a ZipTip pipette tip, filtered through solid-phase extraction (SPE) using homemade columns containing R1 or R3 resin or OASIS hydrophilic–lipophilic balance (HLB) cartridges, or applied to one of 3 different Empore extraction disks (ANION SR, SDB-XC, or chelating). Prior to preparation using ZipTip, some aliquots were ultra-filtered using Vivaspin 500 10 kDa or 50 kDa MWCO. Optimization of MALDI-TOF analysis was conducted with proteins prepared using OASIS HLB cartridges. The effect of diagnosis was investigated using mid-stream early morning urine from 30 healthy individuals and 30 patients with prostate cancer processed according to the identified optimal protocol.

Summary of Findings

Urine that was not ultrafiltered before ZipTip preparation had few proteins of 1,000–12,000 Da, but the number of proteins detected increased slightly when the 50 kDa filter was used and larger increases were noted when the 10 kDa filter was used before ZipTip preparation. Importantly, the spectra obtained by the three methods were completely different. HLB resin cartridges resulted in more peaks in the spectra than columns packed with R1 or R3 resin or ANION SR, SDB-XC, or chelating extraction disks and also resulted in enrichment of the LMW peaks.

The highest peak intensities and largest number of peaks were obtained when CHCA was the matrix rather than SA or a mixture of CHCA and SA. A 1:1 urine to analyte matrix ratio was superior to 1:3 or 1:5 ratios. Sample deposition by spin coating rather than the dried droplet method resulted in the highest peak intensities and lowest standard deviation and coefficient of variance between spots.

Significant differences in urinary protein profiles were found among individuals with the same diagnosis making it hard to identify biomarkers. Further, no significant differences in the protein profile were identified between the pooled urine from 30 healthy individuals and the pooled urine from 30 patients with prostate cancer but some small differences were observed.

  • Biospecimens

    FluidUrine
  • Preservation Types

    None (Fresh)
  • Diagnoses

    NeoplasticCarcinoma
    Normal
  • Platforms

    ProteinMALDI-TOF MS
    PeptideMALDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Healthy
    Prostate cancer
    Analyte Extraction and PurificationAnalyte isolation method
    ANION SR Empore extraction disk
    Chelating Empore extraction disk
    Column containing R3 resin
    Columns containing R1 resin
    OASIS HLB cartridge
    SDB-XC Empore extraction disk
    Ultrafiltered using Vivaspin 500 10 kDa MWCO before ZipTip
    Ultrafiltered using Vivaspin 500 50 kDa MWCO before ZipTip
    ZipTip alone
    MALDI-TOF MS SpecificResin
    CHCA
    Mixture of CHCA and SA
    SA
    MALDI-TOF MS SpecificTemplate/input amount
    1:1 ratio
    1:3 ratio
    1:5 ratio